Chargement de la fiche…
Chargement de la fiche…
Activité mixte
Photo : Wolfgang Staudt from Saarbruecken, Germany, CC BY 2.0, Wikimedia Commons
Vous êtes Dre Charlotte Hua ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dre Charlotte Hua est rhumatologue à Montpellier (34295). Elle consulte notamment à HOPITAL LAPEYRONIE CHU MONTPELLIER, 371 Avenue DU DOYEN GASTON GIRAUD, 34295 Montpellier (2 lieux au total). Elle exerce en secteur 2 et accepte la carte Vitale.
Consulter
HOPITAL LAPEYRONIE CHU MONTPELLIER
371 Avenue DU DOYEN GASTON GIRAUD, 34295 Montpellier
Hospitalier
Dre Charlotte Hua, c'est vous ?
Faites de cette fiche la page de votre cabinet.
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'études spécialisées
DE Docteur en médecine · DIU Pathologies osseuses médicales · DIU Etudes approfondies polyarthrites-maladies — Capacité / certificat d'études spéciales
DIU Pathologies osseuses médicales
Diplôme de référence pour l'ostéoporose et les maladies osseuses rares. Inclut prise en charge densitométrie, biothérapies anti-fracturaires, parathormone.
Plusieurs universités françaises
DIU Études approfondies polyarthrites & maladies auto-immunes
Le DIU rhumato généraliste de référence : polyarthrite rhumatoïde, spondyloarthrite, lupus, Sjögren, vascularites. Coordonné par la SFR.
Plusieurs universités, coordination Société Française de Rhumatologie (SFR)
2025–2026
Centre Hospitalier Universitaire de Nîmes
2021–2022
Inserm
2015–2022
Université de Montpellier
2017–2022
Centre Hospitalier Universitaire de Nîmes
2021
Centre Hospitalier Universitaire de Montpellier
2016–2019
Centre Hospitalier Universitaire Henri-Mondor
travaux indexés
citations
h-index
i10
Indicateurs calculés par OpenAlex (base bibliographique ouverte) · ORCID 0000-0002-7437-377X.
En bref
Dre Charlotte Hua exerce dans 2 lieux : HOPITAL LAPEYRONIE CHU MONTPELLIER, 371 Avenue DU DOYEN GASTON GIRAUD, 34295 Montpellier et CABINET DU DR Charlotte HUA, 16 AVENUE D ASSAS, 34000 Montpellier. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 04 67 33 67 33 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Oui, en secteur 2 (honoraires libres, dépassements possibles). Source : Assurance Maladie.
Oui, y compris l'application carte Vitale sur téléphone. Source : Assurance Maladie.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Rhumatologues à Montpellier →Rhumatologues en Hérault (34) →
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Montpellier, j'accompagne…
Exemple : vous choisissez vos propres domaines.
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
2026Molecular and cellular biochemistryPubMed
ACSL1 orchestrates ferroptosis and degranulation in low-density neutrophils: a novel pathogenic mechanism and therapeutic target in systemic lupus erythematosus
2026Rheumatology (Oxford, England)PubMed
Single-cell transcriptome-wide Mendelian randomization and colocalization reveal cell-specific mechanisms in systemic lupus erythematosus
2025International journal of rheumatic diseasesPubMed
Palmitoylation Dynamics in Systemic Lupus Erythematosus: Multi-Omics Insights and Potential Therapeutic Implications
2025Ecotoxicology and environmental safetyPubMed
Prioritizing endocrine-disrupting chemicals targeting systemic lupus erythematosus genes via Mendelian randomization and colocalization analyses
2025Clinical rheumatologyPubMed
Exploring the molecular mechanism of Tripterygium Wilfordii Hook F in treating systemic lupus erythematosus via network pharmacology and molecular docking
2025Journal of inflammation researchPubMed
Identification of RSAD2 as a Key Biomarker Linking Iron Metabolism and Dendritic Cell Activation in Systemic Lupus Erythematosus Through Bioinformatics and Experimental Validation
2024International immunopharmacologyPubMed
Promising roles of combined therapy based on immune response and iron metabolism in systemic lupus erythematosus
2023Advances in rheumatology (London, England)PubMed
Risk factors of systemic lupus erythematosus: an overview of systematic reviews and Mendelian randomization studies
2021Frontiers in immunologyPubMed
Promising Roles of Exosomal microRNAs in Systemic Lupus Erythematosus
2017International immunopharmacologyPubMed
A novel small molecule compound possesses immunomodulatory properties on bone marrow-derived dendritic cells via TLR7 signaling pathway and alleviates the development of SLE
2026Autoimmunity reviewsPubMed
Ferritinophagy in inflammatory and autoimmune diseases: Mechanistic insights and therapeutic potentials
2023The Cochrane database of systematic reviewsPubMed
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
2022The Cochrane database of systematic reviewsPubMed
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
2021The Cochrane database of systematic reviewsPubMed
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
2026Free radical biology & medicinePubMed
Heme oxygenase-1-enriched tolerogenic dendritic cell-derived exosomes attenuate lupus nephritis by restoring immune balance and iron homeostasis
2026International immunopharmacologyPubMed
Mitochondrial kinase CMPK2 in immune homeostasis and disease: from metabolic regulation to inflammatory signaling
2026ACS applied materials & interfacesPubMed
An Engineered SIM@ZIF-8 Hydrogel Synergistically Enhances Vascularized Bone Regeneration in an Osteoporotic Environment
2025Pharmacological researchPubMed
Effects of natural products on macrophage immunometabolism: A new frontier in the treatment of metabolic diseases
2023The Cochrane database of systematic reviewsPubMed
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
2022The Cochrane database of systematic reviewsPubMed
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
2021The Cochrane database of systematic reviewsPubMed
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
2020The Cochrane database of systematic reviewsPubMed
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
2022Joint bone spinePubMed
Impact of multimorbidity on disease modifying antirheumatic drug therapy in early rheumatoid arthritis: Data from the ESPOIR cohort
2020RMD openPubMed
Glucocorticoids in rheumatoid arthritis: current status and future studies
2020Arthritis care & researchPubMed
Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review
2019Joint bone spinePubMed
Update of French society for rheumatology recommendations for managing rheumatoid arthritis
2020Arthritis care & researchPubMed
Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review
2019Annals of the rheumatic diseasesPubMed
Response to: 'Metabolic and cardiovascular benefits of hydroxychloroquine: exploration in a wider population at high CV risk' by Pareek et al
2018Annals of the rheumatic diseasesPubMed
Response to: 'Cardiovascular effects of hydroxychloroquine: a systematic review and meta-analysis' by Mathieu et al
2018Annals of the rheumatic diseasesPubMed
Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis
2017Annals of the rheumatic diseasesPubMed
2016 update of the EULAR recommendations for the management of early arthritis
2017RMD openPubMed
Diagnosis, prognosis and classification of early arthritis: results of a systematic review informing the 2016 update of the EULAR recommendations for the management of early arthritis
2017RMD openPubMed
Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis
2026Phytomedicine : international journal of phytotherapy and phytopharmacologyPubMed
Evaluation of the clinical efficacy of Xanthoceras sorbifolium leaves in intervening in hyperuricemia and research on its uric acid-lowering mechanism
2026Current pharmaceutical designPubMed
Exploring Potential Treatments - Research Progress on Natural Product Alkaloids Against Gout
2025Clinical and experimental rheumatologyPubMed
Machine learning-based identification of pyroptosis-related genes as biomarkers and targets in primary Sjögren's syndrome
2025Inflammation research : official journal of the European Histamine Research Society ... [et al.]PubMed
Exosomes as immunomodulators in autoimmune inflammation: implications for primary Sjögren's disease
2026 · Article
Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis Atlas
2022 · Article
Impact de la multimorbidité sur la réponse thérapeutique aux traitements de fond antirhumatismaux dans la polyarthrite rhumatoïde récente : données de la cohorte Espoir
2022 · Article
Impact of multimorbidity on disease modifying antirheumatic drug therapy in early rheumatoid arthritis: Data from the ESPOIR cohort
2020 · Article
Glucocorticoids in rheumatoid arthritis: current status and future studies
2019 · Article
Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review
2019 · Article
Update of French society for rheumatology recommendations for managing rheumatoid arthritis
2019 · Article
Actualisation des Recommandations de la Société française de rhumatologie pour la prise en charge de la polyarthrite rhumatoïde
2018 · Article
Response to eLetter: ‘Cardiovascular effects of hydroxychloroquine: a systematic review and meta-analysis’ by Mathieu et al
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.
2020The Cochrane database of systematic reviewsPubMed
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
2023Inflammation research : official journal of the European Histamine Research Society ... [et al.]PubMed
Agomir miRNA-150-5p alleviates pristane-induced lupus by suppressing myeloid dendritic cells activation and inflammation via TREM-1 axis
2017The Cochrane database of systematic reviewsPubMed
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
2018Annals of the rheumatic diseasesPubMed
Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis